Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M

Generic drugs giant Dr. Reddy’s Laboratories has made a deal to acquire Mayne Pharma’s US generics portfolio for at least $90 million.

Mayne Pharma sells about 45 different generics products in the US, Dr. Reddy’s said in a release announcing the sale, including generics in women’s health.